Rate My Professor Teagan Edwards

Currently, Dr Edwards is investigating myeloperoxidase—an enzyme secreted by immune cells to counter pathogens—as a non-invasive biomarker for assessing inflammation in children with inflammatory bowel disease (IBD). Her notable publications include: "Fecal myeloperoxidase levels reflect disease activity in children with Crohn’s disease" (Edwards et al., Inflammatory Bowel Diseases, 31:800-811, 2025); "Myeloperoxidase enzyme activity in feces reflects endoscopic severity in inflammatory bowel disease" (Borichevsky et al., Inflammatory Bowel Diseases, 2025); "Biomarkers of oxidative and mitochondrial stress are associated with accelerated pace of aging at midlife in a birth cohort" (King-Hudson et al., Journals of Gerontology Series A, 2025); "Simulated gastrointestinal digestion of milk caseins containing A1 β-casein does not lead to increased production of inflammatory proteins in intestinal epithelial cells in vitro when compared to milk caseins containing A2 β-casein" (Aitchison et al., Journal of Functional Foods, 125:106669, 2025); and "Simulated gastrointestinal digestion of bovine A1 β-casein does not increase production of inflammatory proteins in vitro compared to A2 β-casein" (Aitchison et al., Journal of Gastroenterology & Hepatology, 40 (Suppl. 1), 2025). In recognition of her work, she was awarded a $109,992 Major Projects Grant from the Canterbury Medical Research Foundation in 2023 to evaluate a myeloperoxidase blood test for detecting inflammation in children with IBD. She also received a CMRF Major Project Grant in 2025 for research on inflammatory bowel disease in children.